Papers
2
Total Citations
14
H-Index
2
About
Shu Cui is a rising figure in urologic oncology, specializing in the comparative effectiveness of surgical approaches for kidney and bladder cancers. His work centers on evaluating minimally invasive techniques—particularly robot-assisted and laparoscopic surgery—against traditional open procedures, with a focus on optimizing perioperative outcomes and patient safety. In a 2024 systematic review and meta-analysis, Cui compared robot-assisted transperitoneal versus retroperitoneal partial nephrectomy for posterior-lateral renal tumors, synthesizing data to guide surgical decision-making (8 citations). His 2020 Bayesian network analysis of open, laparoscopic, and robot-assisted radical cystectomy for bladder cancer represents a methodological advance, using network meta-analysis to rank treatments by safety and efficacy (6 citations). Though early in his career, Cui’s contributions demonstrate a commitment to evidence-based surgery, leveraging advanced statistical techniques to clarify complex clinical trade-offs. His research has immediate relevance for surgeons selecting approaches that reduce complications while maintaining oncologic control, making him a promising voice in the evolution of urologic practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2